Wu-Sheng Deng (Wusheng Deng)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Metastatic Colorectal Cancer

Molecular Docking

Tyrosine Kinase

Top Venues

Infection and drug resistance

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Wu-Sheng Deng, Yun Jiang, Jiaoxia Qin, Gang Chen, Yongjie Lv, Yanmei Lei, Jing Luo, Kangkang Hong, Bing Huang, Luhai Qin, Xiujia Tang, Liumei Ye, Yuhai Dang, Chao Wang, Feiyang Long, Ke Wang, Jinliang Kong
Metagenomic Next-Generation Sequencing Assists in the Diagnosis of Mediastinal Aspergillus fumigatus Abscess in an Immunocompetent Patient: A Case Report and Literature Review. Infection and drug resistance 16 (2023)
Wu-Sheng Deng, Ke Wang, Yun Jiang, Dingbin Li, Chongxi Bao, Jing Luo, Liuyuan Liu, Bing Huang, Jinliang Kong
Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR -positive advanced non-small-cell lung cancer: a systematic review and meta-analysis of randomised controlled trials. BMJ open 12 (8) (2022)
Bing Huang, Jing Luo, Liu-Yuan Liu, Wu-Sheng Deng, Ke Wang, Hua-Song Lu, Jin-Liang Kong
Deciphering the Mechanism of YuPingFeng Granules in Treating Pneumonia: A Network Pharmacology and Molecular Docking Study. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)